The authors reply to comments on “The lymphocyte transformation test for the diagnosis of Lyme borreliosis has currently not been shown to be clinically useful.” Clin Microbiol Infect 2014;20:O786–O787  by Dessau, R.B. et al.
LETTER TO THE EDITOR INFECTIOUS DISEASESThe authors reply to comments on “The
lymphocyte transformation test for the
diagnosis of Lyme borreliosis has currently
not been shown to be clinically useful.” Clin
Microbiol Infect 2014;20:O786–O787R. B. Dessau1, V. Fingerle2, J. Gray3, K.-P. Hunfeld4,
B. Jaulhac5, W. Kristoferitsch6, G. Stanek7 and F. Strle8
1) Region Zealand, Clinical Microbiology, Denmark, 2) Bavarian Health and
Food Safety Authority, National Reference Centre for Borrelia,
Germany, 3) University College Dublin, Biology and Environmental Science,
Ireland, 4) Northwest Medical Centre, Academic Teaching Hospital, Institute
for Laboratory Medicine, Microbiology & Infection control,
Germany, 5) Universite de Strasbourg, Institute of Bacteriology,
France, 6) SMZ-Ost-Donauspital, Karl Landsteiner Institute for
Neuroimmunological and Neurodegenerative Disorders, Austria, 7) Medical
University Vienna, Hygiene & Medical Microbiology, Austria and 8) University
Medical Centre Ljubljana, Department of Infectious Diseases, Slovenia
Original Submission: 11 July 2014; Accepted: 5 August 2014
Editor: D. Raoult
Article published online: 29 October 2014Corresponding author: Ram B. Dessau, Department of clinical
microbiology Slagelse Hospital, Region Zealand, Denmark 18
Ingemannsvej, DK4200 Slagelse Denmark
E-mail: Ramd@regionsjaelland.dkVon Baehr et al. have provided comments to our letter titled
“The lymphocyte transformation test for the diagnosis of Lyme
borreliosis has currently not been shown to be clinically useful”
[1]. We would like to thank Dr. von Baehr for providing the
additional information that the clinical diagnoses were adaptedClinical Microbiology and Infection © 2014 European Society of Cfrom the patient’s health record. However, we still do not
know the details of how it was ensured that the 94 patients
really suffered from clinical Lyme borreliosis (LB).
We agree that the speciﬁcity of the lymphocyte trans-
formation test (LTT) was high in the seronegative controls and
low in the seropositive controls. However, we do not agree
that 8.4% LTT positive in 48 seropositive healthy controls
speaks for a high analytical speciﬁcity. Concerning point 2,
speciﬁcity is not usually determined by data from patients, but
in controls assumed to be without the disease in question. This
point is therefore invalid. We maintain that it was not possible
to determine whether or not antibiotic treatment inﬂuenced T-
cell reactivity because the study was not designed appropriately.
We also maintain that it has not been established that the LTT
is able to give “additional evidence” and to function as an
extension to serological methods. If a test is put into routine
use, then many patients without LB are tested. If 1000 tests
were performed on seropositive patients without LB, then an
additional 84 false-positive results would be found. Thus, using
additional LTT could reduce diagnostic accuracy.
Concerning the 5 studies listed by von Baehr, in the limited
space available to us we chose to focus on the methodological
problems in the von Baehr study [2] and cited authoritative
studies that had previously reviewed LTT and similar methods.
It may be that in time the LTT method will be shown to have
clinical relevance for the diagnosis of LB, but at present the
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